Synopsis
1) To propose a step-by-step approach for standardized MRI staging of pre-treatment rectal carcinoma using the mnemonic "DISTANCE".
2) To become familiar with the different treatment strategies and organ preservation in rectal cancer.
3) To know the performance of modern MRI for the prediction of treatment response.
4) To learn how to evaluate response after chemoradiotherapy and understand how MRI findings may alter surgical approach and affect the likelihood of local and distant recurrence.
LEARNING OBJECTIVES:
1)
To propose a step-by-step approach for
standardized MRI staging of pre-treatment rectal carcinoma using the mnemonic
"DISTANCE".
2)
To become familiar with the different treatment
strategies and organ preservation in rectal cancer.
3)
To know
the performance of modern MRI for the prediction of treatment response.
4)
To learn how to evaluate response after chemoradiotherapy
and understand how MRI findings may alter surgical approach and affect the
likelihood of local and distant recurrence.
ABSTRACT:
Recent changes in the
management of patients with locally advanced rectal cancer highlight the need
for accurate assessment of tumor response to chemoradiation (CRT). In the past,
CRT was followed by surgical resection in nearly all patients, irrespective of
response to CRT. However, new data suggest that surgery may not be necessary in
patients with complete response. MR imaging has become an essential tool to
enable the oncology team to make appropriate treatment decisions. MRI has so
far relied on changes in morphology as a measurement for response. However, this
evaluation is hampered by the difficulties in differentiating residual tumor
from radiation-induced fibrosis. Recent studies have suggested that adding
diffusion-weighted imaging (DWI) to conventional MRI can aid this
differentiation and thus improve the prediction of response after neoadjuvant
therapy.
The learning objectives
of this lecture are first to know the performance of modern MR imaging for the diagnosis
and assessment of response in rectal cancer and to understand how MRI
influences treatment. Second, we will use the mnemonic “DISTANCE” ((DIS, for Distance from the
Inferior part of the tumor to the transitional Skin; T, for T staging; A, for
Anal complex; N, for Nodal staging; C, for Circumferential resection margin;
and E, for Extramural vascular invasion) to emphasize the diagnostic clues to
interpret rectal MR images before and after CRT.
MAIN DIAGNOSIS TIPS AND
TAKE HOME MESSAGES
Clues at the Workstation for T staging (disTance):
-T stage must be assessed on planes strictly perpendicular to the tumor.
Incorrect prescription of the acquisition plane leads to blurring of the
muscularis propria and may lead to overstaging.
-In differentiating between stage T2 and T3 tumors,
the crucial criterion is involvement of the perirectal fat. In stage T3, the
muscularis propria is completely disrupted and cannot be clearly distinguished
from the perirectal fat: The tumor spreads beyond the muscularis propria into
the perirectal fat with a broad-based bulge or nodular appearance.
-Outer longitudinal layer of the muscularis propria
can be focally disrupted by small vessels penetrating the wall; this does not
necessarily indicate tumor invasion.
-Peritoneal reflection must be assessed in upper
rectal tumors. It may be identified on sagittal T2W images as a low-signal
linear structure that can be seen extending from the posterior aspect of the
dome of the bladder to the ventral aspect of the rectum. On axial, the point of
attachment has a V-shaped configuration
Clues at the Workstation for staging low lying
tumors (distAnce):
-High-spatial-resolution
T2W FSE coronal imaging must be added to optimally depict the tumor
relationship with the levator and puborectal muscles, sphincter complex, and
intersphincteric plane.
-On
coronal T2W images, the commencement of the puborectalis sling marks the start
of the narrowest part of the mesorectum; below lies the anal canal. The first
question to answer in low lying tumors is where the lower edge of the tumor is
located in relation to the puborectalis sling: if the tumor is located above
the puborectalis sling, sphincter involvement can be easily excluded.
-When
the tumor extends below the puborectalis sling: 3 areas have to be evaluated
and reported on: Muscularis propria: Does the tumor invade
partially or the full thickness of the muscularis propria (Stage T1 versus T2)
Is there an extension into the
intersphincteric plane (Stage T3)?
Is there an extension into the external
sphincter (Stage T4)?
-Levator,
puborectalis muscles or external sphincter involvement are considered as Stage
T4.
Clues at the Workstation for Nodal staging (distaNce):
-Uniform nodes with
homogeneous signal intensity are not
suspicious.
-Nodes with irregular borders,
mixed signal intensity, or both are considered to be suspicious.
-One to three suspicious nodes is
stage N1 and four or more is stage N2.
-Any
lymph node lying within 1 mm of the circumferential resection margin must be reported
because it is highly suspicious of CRM involvement.
-Recording
the location and size of any suspicious pelvic sidewall lymph nodes is
critical. This will inform the radiotherapy team to
change and adjust the radiotherapy field. Secondly, the surgeon will need to
perform an extended lymph node resection with additional removal of the
internal iliac nodes. This lymph node group is not removed when a regular TME
is performed.
Clues at the workstation for a Positive CRM (circumferential resection margin) (distanCe):
-The mesorectal fascia represents the potential CRM in patients
undergoing total mesorectal excision surgery.
-A positive margin is defined as tumor lying within 1mm
of the mesorectal fascia.
-Positive margins can be due to tumor
deposits, main tumor extension, extramural vascular invasion, or suspicious
lymph nodes
-Anteriorly the mesorectal fat can be
thin, and the rectum can be close to the CRM. In cases where the rectum abuts
the mesorectal fascia anteriorly; the tumor must be at least a Stage T3 before
discussing CRM involvement.
Clues
at the workstation for EVMI (distancE; extramural vascular invasion):
-By definition, EMVI
must be associated with tumors that are at least category T3.
-Signs suggestive for EMVI: Presence of tumor signal intensity within a vascular structure. Expanded
vessels. Tumoral
expansion through and beyond the vessel wall, disrupting the vessel border.
-Finally,
If extramural venous invasion is present, considerations of whether the
involved veins threaten the mesorectal fascia
(i.e., whether they are within 1 mm of the fascia) have to be made.
Acknowledgements
No acknowledgement found.References
1. Nougaret S,
Reinhold C, Mikhael HW, Rouanet P, Bibeau F, Brown G. The use of MR imaging in
treatment planning for patients with rectal carcinoma: have you checked the
"DISTANCE"? Radiology. 2013;268(2):330-44.
2.
Taylor F, Mangat N, Swift IR, Brown G. Proforma-based
reporting in rectal cancer. Cancer Imaging 2010;10 Spec no A:S142-50.
3.
Brown G, Richards CJ, Newcombe RG, et al. Rectal
carcinoma: thin-section MR imaging for staging in 28 patients. Radiology
1999;211(1):215-22.
4.
Beets-Tan RG. MRI in rectal cancer: the T stage and
circumferential resection margin. Colorectal Dis 2003;5(5):392-5.
5.
Beets-Tan RG, Beets GL, Vliegen RF, et al. Accuracy of
magnetic resonance imaging in prediction of tumour-free resection margin in
rectal cancer surgery. Lancet 2001;357(9255):497-504.
6.
Extramural depth of tumor invasion at thin-section MR
in patients with rectal cancer: results of the MERCURY study. Radiology
2007;243(1):132-9.
7.
Smith N, Brown G. Preoperative staging of rectal cancer.
Acta Oncol 2008;47(1):20-31.
8.
Shihab OC, How P, West N, et al. Can a novel MRI
staging system for low rectal cancer aid surgical planning? Dis Colon Rectum
2011;54(10):1260-4.
9.
Shihab OC, Moran BJ, Heald RJ, Quirke P, Brown G. MRI
staging of low rectal cancer. Eur Radiol 2009;19(3):643-50.
10.
Brown G, Richards CJ, Bourne MW, et al. Morphologic
predictors of lymph node status in rectal cancer with use of
high-spatial-resolution MR imaging with histopathologic comparison. Radiology
2003;227(2):371-7.
11.
Kim JH, Beets GL, Kim MJ, Kessels AG, Beets-Tan RG.
High-resolution MR imaging for nodal staging in rectal cancer: are there any
criteria in addition to the size? Eur J Radiol 2004;52(1):78-83.
12.
Smith NJ, Barbachano Y, Norman AR, Swift RI, Abulafi
AM, Brown G. Prognostic significance of magnetic resonance imaging-detected
extramural vascular invasion in rectal cancer. Br J Surg 2008;95(2):229-36.
13.
Kim SH, Lee JM, Hong SH, et al. Locally advanced
rectal cancer: added value of diffusion-weighted MR imaging in the evaluation
of tumor response to neoadjuvant chemo- and radiation therapy. Radiology
2009;253(1):116-25.
14.
Sun YS, Zhang XP, Tang L, et al. Locally advanced
rectal carcinoma treated with preoperative chemotherapy and radiation therapy:
preliminary analysis of diffusion-weighted MR imaging for early detection of
tumor histopathologic downstaging. Radiology 2010;254(1):170-8.
15.
Lambregts DM, Vandecaveye V, Barbaro B, et al.
Diffusion-Weighted MRI for Selection of Complete Responders After
Chemoradiation for Locally Advanced Rectal Cancer: A Multicenter Study. Ann
Surg Oncol 2011;18(8):2224-2231.
16. Lambrecht M,
Vandecaveye V, De Keyzer F, et al. Value of Diffusion-Weighted Magnetic
Resonance Imaging for Prediction and Early Assessment of Response to
Neoadjuvant Radiochemotherapy in Rectal Cancer: Preliminary Results. Int J
Radiat Oncol Biol Phys 2012;82(2):863–870.
17.
Patel UB, Taylor F, Blomqvist L, et al. Magnetic
resonance imaging-detected tumor response for locally advanced rectal cancer
predicts survival outcomes: MERCURY experience. J Clin Oncol
2011;29(28):3753-60.
18.
Yeo SG, Kim DY, Kim TH, et al. Tumor volume reduction
rate measured by magnetic resonance volumetry correlated with pathologic tumor
response of preoperative chemoradiotherapy for rectal cancer. Int J Radiat Oncol
Biol Phys 2010;78(1):164-71.
19.
Curvo-Semedo L, Lambregts DM, Maas M, et al. Rectal
cancer: assessment of complete response to preoperative combined radiation
therapy with chemotherapy--conventional MR volumetry versus diffusion-weighted
MR imaging. Radiology 2011;260(3):734-43.
20.
Barbaro B, Fiorucci C, Tebala C, et al. Locally
advanced rectal cancer: MR imaging in prediction of response after preoperative
chemotherapy and radiation therapy. Radiology 2009;250(3):730-9.
21. Nougaret S,
Rouanet P, Molinari N, et al. MR Volumetric Measurement of Low Rectal Cancer
Helps Predict Tumor Response and Outcome after Combined Chemotherapy and
Radiation Therapy. Radiology 2012;
263(2): 409-418
22.
Vliegen RF, Beets GL, Lammering G, et al. Mesorectal
fascia invasion after neoadjuvant chemotherapy and radiation therapy for
locally advanced rectal cancer: accuracy of MR imaging for prediction.
Radiology 2008;246(2):454-62.
23.
Salerno G, Daniels IR, Moran BJ, Wotherspoon A, Brown
G. Clarifying margins in the multidisciplinary management of rectal cancer: the
MERCURY experience. Clin Radiol 2006;61(11):916-23.